Rein Piir

Mr. Rein Piir is an Independent Director at IRLAB Therapeutics AB and a Chairman & Chief Executive Officer at Piir & Partner AB. He is on the Board of Directors at IRLAB Therapeutics AB, L E Svensson Snickeri AB, Lesvensson Snickeri AB and Trygga Pengar I Mobilen Sverige AB. Mr. Piir was previously employed as a Vice President-Investor Relations by Alligator Bioscience AB, a Head-Investor Relations by Oncopeptides AB, a Vice President & Head-Investor Relations by Camurus AB, an EVP-Corporate Affairs & Investor Relations by Medivir AB, a Head-Strategy by Alecta AB, a Head-Analysis by Carnegie Investment Bank AB, and an Auditor by PricewaterhouseCoopers AB. He also served on the board at Cereno Scientific AB, Hw Svenskt Reklamscreen AB and Medivir Personal AB. He received his graduate degree from the University of Uppsala.